Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–20.

CAS  Article  Google Scholar 

Goergen J, Bavishi A, Eimer M, Zielinski AR. COVID-19: the risk to athletes. Curr Treat Options Cardiovasc Med. 2021;23(11):68.

Article  Google Scholar 

Bauer P, Kraushaar L, Dörr O, Keranov S, Nef H, Hamm CW, et al. Vascular alterations among male elite athletes recovering from SARS-CoV-2 infection. Sci Rep. 2022;12(1):8655.

CAS  Article  Google Scholar 

Alosaimi B, AlFayyad I, Alshuaibi S, Almutairi G, Alshaebi N, Alayyaf A, et al. Cardiovascular complications and outcomes among athletes with COVID-19 disease: a systematic review. BMC Sports Sci Med Rehabil. 2022;14:74.

Article  Google Scholar 

Rajpal S, Tong MS, Borchers J, Zareba KM, Obarski TP, Simonetti OP, et al. Cardiovascular magnetic resonance findings in competitive athletes recovering from COVID-19 infection. JAMA Cardiol. 2021;6(1):116–8.

PubMed  Google Scholar 

•• Kim JH, Levine BD, Phelan D, Emery MS, Martinez MW, Chung EH, et al. Coronavirus disease 2019 and the athletic heart: emerging perspectives on pathology, risks, and return to play. JAMA Cardiol. 2021;6(2):219–27. Guidelines for sport return.

Clark DE, Parikh A, Dendy JM, Diamond AB, George-Durrett K, Fish FA, et al. COVID-19 Myocardial pathology evaluation in athletes with cardiac magnetic resonance (COMPETE CMR). Circulation. 2021;143(6):609–12.

CAS  Article  Google Scholar 

Topol EJ. COVID-19 can affect the heart. Science. 23 de outubro de. 2020;370(6515):408–9.

Fox SE, Lameira FS, Rinker EB, Vander Heide RS. Cardiac endotheliitis and multisystem inflammatory syndrome after COVID-19. Ann Intern Med. 2020;173(12):1025–7.

Article  Google Scholar 

Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA. 2020;324(8):782–93.

CAS  Article  Google Scholar 

Brito D, Meester S, Yanamala N, Patel HB, Balcik BJ, Casaclang-Verzosa G, et al. High prevalence of pericardial involvement in college student athletes recovering from COVID-19. JACC Cardiovasc Imaging. 2021;14(3):541–55.

Article  Google Scholar 

Feldstein LR, Rose EB, Horwitz SM, Collins JP, Newhams MM. Son MBF et al Multisystem inflammatory syndrome in US children and adolescents. N Engl J Med. 2020;383(4):334–46.

CAS  Article  Google Scholar 

Ackermann M, Verleden SE, Kuehnel M, Haverich A, Welte T, Laenger F, et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N Engl J Med. 2020;383(2):120–8.

CAS  Article  Google Scholar 

Brawner CA, Ehrman JK, Bole S, Kerrigan DJ, Parikh SS, Lewis BK, et al. Inverse relationship of maximal exercise capacity to hospitalization secondary to coronavirus disease 2019. Mayo Clin Proc. 2021;96(1):32–9.

CAS  Article  Google Scholar 

Zbinden-Foncea H, Francaux M, Deldicque L, Hawley JA. Does high cardiorespiratory fitness confer some protection against proinflammatory responses after infection by SARS-CoV-2? Obes Silver Spring Md. 2020;28(8):1378–81.

CAS  Article  Google Scholar 

Wilson MG, Hull JH, Rogers J, Pollock N, Dodd M, Haines J, et al. Cardiorespiratory considerations for return-to-play in elite athletes after COVID-19 infection: a practical guide for sport and exercise medicine physicians. Br J Sports Med. 2020;54(19):1157–61.

Article  Google Scholar 

Brosnan MJ, Rakhit D. Differentiating athlete’s heart from cardiomyopathies - the left side. Heart Lung Circ. 2018;27(9):1052–62.

Article  Google Scholar 

Moulson N, Petek BJ, Drezner JA, Harmon KG, Kliethermes SA, Patel MR, et al. SARS-CoV-2 cardiac involvement in young competitive athletes. Circulation. 2021;144(4):256–66.

CAS  Article  Google Scholar 

•• Maron BJ, Udelson JE, Bonow RO, Nishimura RA, Ackerman MJ, Estes NAM, et al. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 3: hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy and other cardiomyopathies, and myocarditis: a scientific statement from the American Heart Association and American College of Cardiology. Circulation. 2015;132(22):e273-280. Guidelines for the management of athletes with cardiovascular abnormalities.

PubMed  Google Scholar 

Phelan D, Kim JH, Elliott MD, Wasfy MM, Cremer P, Johri AM, et al. Screening of potential cardiac involvement in competitive athletes recovering from COVID-19: an expert consensus statement. JACC Cardiovasc Imaging. 2020;13(12):2635–52.

Article  Google Scholar 

Tasca JS, Bianchi G, Girardello A, Lucchini A, Cappelli C. Cardiac involvement in athletes infected by SARS COV-2 disease. Sci Sports. 2022;37(3):167–75.

CAS  Article  Google Scholar 

Eichhorn C, Bière L, Schnell F, Schmied C, Wilhelm M, Kwong RY, et al. Myocarditis in athletes is a challenge: diagnosis, risk stratification, and uncertainties. JACC Cardiovasc Imaging. 2020;13(2 Pt 1):494–507.

Article  Google Scholar 

Scala I, Rizzo PA, Bellavia S, Brunetti V, Colò F, Broccolini A, et al. Autonomic dysfunction during acute SARS-CoV-2 infection: a systematic review. J Clin Med. 2022;11(13):3883.

CAS  Article  Google Scholar